Skip to main content
C

CELLUMED CO., LTD. — Investor Relations & Filings

Ticker · 049180 ISIN · KR7049180003 KO Manufacturing
Open in API
Filings indexed 396 across all filing types
Latest filing 2023-10-04 Capital/Financing Update
Country KR South Korea
Listing KO 049180

About CELLUMED CO., LTD.

http://www.clnzyme.co.kr/

CELLUMED CO., LTD. is a biotechnology company specializing in the development and manufacturing of medical devices, tissue grafts, and advanced biologics. The company operates as a human tissue bank, producing and supplying a variety of bone graft materials, including allografts and xenografts, for transplantation. Its medical device portfolio features orthopedic implants, with a key product being an artificial knee joint system. In the biologics sector, Cellumed develops growth factors and provides specialized enzymes, such as CLnZyme, which are utilized in the research, development, and production of RNA-based vaccines and therapeutics.

Recent filings

Filing Released Lang Actions
전환가액의조정(제25회차)
Capital/Financing Update Classification · 1% confidence The document is a formal regulatory filing from the Korea Exchange (KRX) regarding the adjustment of the conversion price for convertible bonds (CB). It details the change in conversion price, the number of shares, and the underlying reasons (market price decline). This falls under capital structure changes and financing updates, specifically related to convertible securities. Among the provided categories, 'CAP' (Capital/Financing Update) is the most accurate classification for adjustments to convertible debt terms.
2023-10-04 Korean
전환가액의조정(제25회차)
Share Issue/Capital Change Classification · 1% confidence The document is a formal regulatory filing from the Korea Exchange (KRX) regarding the adjustment of the conversion price for convertible bonds (CB). It details the specific changes to the conversion price, the number of shares, and the underlying reasons (market price decline). This falls under capital structure changes and financing updates, specifically related to convertible securities. Among the provided categories, 'CAP' (Capital/Financing Update) is the most accurate classification for adjustments to conversion prices of debt instruments.
2023-09-04 Korean
증권발행결과(자율공시)(제27회차 CB))
Capital/Financing Update Classification · 1% confidence The document is a formal announcement regarding the result of a securities issuance (specifically a convertible bond, or CB). It details the issuance amount, payment date, and the nature of the security. This falls under the category of capital and financing updates, specifically related to the issuance of debt instruments.
2023-09-01 Korean
주요사항보고서(전환사채권발행결정)
Capital/Financing Update Classification · 1% confidence The document is a 'Major Matter Report' (주요사항보고서) from a South Korean company, Cellumed, detailing the decision to issue convertible bonds (전환사채권 발행결정). This type of filing is a standard regulatory disclosure in the Korean market (DART system) regarding capital structure changes and financing activities. It provides specific terms of the bond, conversion prices, and use of proceeds, which falls under the 'Capital/Financing Update' category.
2023-08-31 Korean
반기보고서 (2023.06)
Interim / Quarterly Report Classification · 1% confidence The document is a '반기보고서' (Semi-Annual Report) for the company 'Cellumed' covering the period from January 1, 2023, to June 30, 2023. It contains detailed financial information, business operations, management discussions, and corporate governance details. According to the filing definitions, a comprehensive financial report for a period shorter than a full fiscal year (like a half-year report) is classified as an Interim / Quarterly Report (IR). H1 2023
2023-08-14 Korean
전환가액의조정(제26회차)
Share Issue/Capital Change Classification · 1% confidence The document is a regulatory filing from the Korean exchange (KRX) regarding the adjustment of the conversion price for convertible bonds (CB). It details the change in conversion price and the resulting change in the number of convertible shares due to market price fluctuations. This type of filing is a standard capital structure update related to financing instruments, which falls under the 'Capital/Financing Update' category.
2023-08-07 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.